Last edition
News about "IMMUNOPRECISE ANTIBODIES LTD"
ImmunoPrecise Introduces PolyTope mAb Therapy To Tackle Coronavirus Pandemic
IMMUNOPRECISE ANTIBODIES LTD, following its announcement to develop innovative treatments against the new coronavirus, SARS-CoV-2, unveils its unique approach utilizing PolyTope mAb Therapy™, enabled by IPA’s diverse discovery platforms and artificial intelligence capabilities with their partner, EVQLV, Inc., in the development of a universal COVID-19
IMMUNOPRECISE ANTIBODIES LTD | 15/03/2020 | By Darshana | 432
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy